Comparison of the analytical performance of the Euroline®, ImmunoCAP®, and ImmunoCAP ISAC 112® in vitro allergen sIgE diagnostic assays in the pediatric arm of the DZL All Age Asthma Cohort (ALLIANCE)

C. Skevaki (Marburg, Germany), A. Dittrich (Hannover, Germany), M. Weckmann (Lubeck, Germany), K. Eiringhaus (Marburg, Germany), N. Timmesfeld (Marburg, Germany), P. Tafo (Marburg, Germany), M. Kopp (Lubeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hannover, Germany), H. Renz (Marburg, Germany)

Source: International Congress 2018 – Paediatric asthma: new mechanisms and tools
Session: Paediatric asthma: new mechanisms and tools
Session type: Thematic Poster
Number: 1313
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Skevaki (Marburg, Germany), A. Dittrich (Hannover, Germany), M. Weckmann (Lubeck, Germany), K. Eiringhaus (Marburg, Germany), N. Timmesfeld (Marburg, Germany), P. Tafo (Marburg, Germany), M. Kopp (Lubeck, Germany), E. Von Mutius (Munich, Germany), G. Hansen (Hannover, Germany), H. Renz (Marburg, Germany). Comparison of the analytical performance of the Euroline®, ImmunoCAP®, and ImmunoCAP ISAC 112® in vitro allergen sIgE diagnostic assays in the pediatric arm of the DZL All Age Asthma Cohort (ALLIANCE). 1313

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: